# FDA Inspection 1168169 - Alison R. Sehgal, MD - April 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/alison-r-sehgal-md/869f8644-1f44-414b-bd22-ce844e4659c5
Source feed: FDA_Inspections

> FDA Inspection 1168169 for Alison R. Sehgal, MD on April 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168169
- Company Name: Alison R. Sehgal, MD
- Inspection Date: 2022-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1134296 - 2020-12-29](https://www.keypedia.com/records/fda_inspections/alison-r-sehgal-md/aef577b3-d3f1-43c4-8a7d-8e6c946bc6c6)
- [FDA Inspection 1134296 - 2020-12-29](https://www.keypedia.com/records/fda_inspections/alison-r-sehgal-md/1f937881-37b3-49b4-bfc1-445ce664e3ab)

Company: https://www.keypedia.com/companies/alison-r-sehgal-md/7fdeb4f9-1334-414c-a4c8-cda454f50267

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d